Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Non-Current Assets (2016 - 2025)

vTv Therapeutics' Non-Current Assets history spans 12 years, with the latest figure at $38000.0 for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 81.55% year-over-year to $38000.0; the TTM value through Sep 2025 reached $376000.0, down 66.9%, while the annual FY2024 figure was $153000.0, 57.62% down from the prior year.
  • Non-Current Assets for Q3 2025 was $38000.0 at vTv Therapeutics, down from $74000.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.4 million in Q2 2021 and bottomed at $38000.0 in Q3 2025.
  • The 5-year median for Non-Current Assets is $6.1 million (2022), against an average of $4.5 million.
  • The largest annual shift saw Non-Current Assets surged 175.03% in 2021 before it crashed 96.96% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $9.9 million in 2021, then tumbled by 37.64% to $6.1 million in 2022, then plummeted by 94.12% to $361000.0 in 2023, then crashed by 57.62% to $153000.0 in 2024, then tumbled by 75.16% to $38000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Non-Current Assets are $38000.0 (Q3 2025), $74000.0 (Q2 2025), and $111000.0 (Q1 2025).